Haemonetics Corporation · NYSE:HAE
Galvin Roy received 27,535 Haemonetics Corporation shares as an award (Form 4)
Traded May 15, 2026 · Filed May 19, 2026
On May 15, 2026, Galvin Roy (EVP, Chief Commercial Officer) received 27,535 Haemonetics Corporation shares as an award, leaving 39,882 shares. Filed May 19, 2026 (Form 4).
- Awarded
- 27,535 shares
- Holding after
- 39,882 shares
- Trading plan
- No
- Role
- EVP, Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Shares withheld for tax | 879 | US$56.29 | 12,347 | Direct |
| May 15, 2026 | Common Stock | Award | 27,535 | 39,882 | Direct |